Valuation
- Market cap
- 38,371,000
- Revenue TTM
- $18,790,000
- Net income TTM
- $1,190,000
- PE ratio
- 32.00
- Forward PE
- 23.47
- Profit margin
- 6.33%
- Debt to equity
- 0.00
Trading
- Volume
- 39,000
- Avg volume
- 34,490
- Day's range
- $3.53 – $3.70
- Shares out
- 10,870,000
- Stochastic %K
- 45%
- Beta
- 1.64
- Analysts
- Sell
- Price target
- $6.25
Company profile
Nephros, Inc., a commercial-stage company, develops and sells water filtration solutions for medical and commercial applications in the United States. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as we...
Show more
Nephros, Inc., a commercial-stage company, develops and sells water filtration solutions for medical and commercial applications in the United States. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in foodservice and hospitality, and other healthcare facilities. The company also manufactures and sells water filters that enhance the taste and odor of water; reduce biofilm and scale build-up; and remove cysts, particulates, and lead from water systems. It markets its products to food service and hospitality sectors including quick-service restaurants, convenience stores, and restaurants. The company was incorporated in 1997 and is headquartered in South Orange, New Jersey.
- Industry
- Medical Instruments & Supplies
- Sector
- Healthcare
- Phone
- 201 343 5202
- Website
- https://www.nephros.com
- Address
- 380 Lackawanna Place, South Orange, United States
Latest news
No headlines yet.